140 related articles for article (PubMed ID: 22939024)
1. Immunising the HIV-infected child: a view from sub-Saharan Africa.
Mphahlele MJ; Mda S
Vaccine; 2012 Sep; 30 Suppl 3():C61-5. PubMed ID: 22939024
[TBL] [Abstract][Full Text] [Related]
2. Immunization of children at risk of infection with human immunodeficiency virus.
Moss WJ; Clements CJ; Halsey NA
Bull World Health Organ; 2003; 81(1):61-70. PubMed ID: 12640478
[TBL] [Abstract][Full Text] [Related]
3. Immunizations in HIV-infected adults.
Rivas P; Herrero MD; Puente S; Ramírez-Olivencia G; Soriano V
AIDS Rev; 2007; 9(3):173-87. PubMed ID: 17982942
[TBL] [Abstract][Full Text] [Related]
4. A review of rotavirus infection in and vaccination of human immunodeficiency virus-infected children.
Steele AD; Cunliffe N; Tumbo J; Madhi SA; De Vos B; Bouckenooghe A
J Infect Dis; 2009 Nov; 200 Suppl 1():S57-62. PubMed ID: 19817615
[TBL] [Abstract][Full Text] [Related]
5. The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children.
Hesseling AC; Marais BJ; Gie RP; Schaaf HS; Fine PE; Godfrey-Faussett P; Beyers N
Vaccine; 2007 Jan; 25(1):14-8. PubMed ID: 16959383
[TBL] [Abstract][Full Text] [Related]
6. Bacille Calmette-Guérin vaccine-induced disease in HIV-infected and HIV-uninfected children.
Hesseling AC; Rabie H; Marais BJ; Manders M; Lips M; Schaaf HS; Gie RP; Cotton MF; van Helden PD; Warren RM; Beyers N
Clin Infect Dis; 2006 Feb; 42(4):548-58. PubMed ID: 16421800
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and efficacy of childhood vaccines in HIV-1-infected children.
Obaro SK; Pugatch D; Luzuriaga K
Lancet Infect Dis; 2004 Aug; 4(8):510-8. PubMed ID: 15288824
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the impact of the HIV pandemic on measles control and elimination.
Helfand RF; Moss WJ; Harpaz R; Scott S; Cutts F
Bull World Health Organ; 2005 May; 83(5):329-37. PubMed ID: 15976873
[TBL] [Abstract][Full Text] [Related]
9. Immunization in the adult immunocompromised host.
Löbermann M; Boršo D; Hilgendorf I; Fritzsche C; Zettl UK; Reisinger EC
Autoimmun Rev; 2012 Jan; 11(3):212-8. PubMed ID: 21621004
[TBL] [Abstract][Full Text] [Related]
10. Immunization in patients with HIV infection: are practical recommendations possible?
Eley B
Drugs; 2008; 68(11):1473-81. PubMed ID: 18627205
[TBL] [Abstract][Full Text] [Related]
11. HIV-infected children living in Central Africa have low persistence of antibodies to vaccines used in the Expanded Program on Immunization.
Tejiokem MC; Gouandjika I; Béniguel L; Zanga MC; Tene G; Gody JC; Njamkepo E; Kfutwah A; Penda I; Bilong C; Rousset D; Pouillot R; Tangy F; Baril L
PLoS One; 2007 Dec; 2(12):e1260. PubMed ID: 18060056
[TBL] [Abstract][Full Text] [Related]
12. Safety, Reactogenicity, and Immunogenicity of Human Rotavirus Vaccine RIX4414 in Human Immunodeficiency Virus-positive Infants in South Africa.
Steele AD; Madhi SA; Louw CE; Bos P; Tumbo JM; Werner CM; Bicer C; De Vos B; Delem A; Han HH
Pediatr Infect Dis J; 2011 Feb; 30(2):125-30. PubMed ID: 20842070
[TBL] [Abstract][Full Text] [Related]
13. Safety of the pentavalent rotavirus vaccine (PRV), RotaTeq(®), in Kenya, including among HIV-infected and HIV-exposed infants.
Laserson KF; Nyakundi D; Feikin DR; Nyambane G; Cook E; Oyieko J; Ojwando J; Rivers SB; Ciarlet M; Neuzil KM; Breiman RF
Vaccine; 2012 Apr; 30 Suppl 1():A61-70. PubMed ID: 22520138
[TBL] [Abstract][Full Text] [Related]
14. The immunogenicity and safety of live attenuated varicella-zoster virus vaccine in human immunodeficiency virus-infected children.
Taweesith W; Puthanakit T; Kowitdamrong E; Bunupuradah T; Wongngam W; Phasomsap C; Apornpong T; Bouko C; Pancharoen C
Pediatr Infect Dis J; 2011 Apr; 30(4):320-4. PubMed ID: 20975615
[TBL] [Abstract][Full Text] [Related]
15. HIV infection and routine childhood immunization: a review.
Clements CJ; von Reyn CF; Mann JM
Bull World Health Organ; 1987; 65(6):905-11. PubMed ID: 3325188
[TBL] [Abstract][Full Text] [Related]
16. [Immunosuppression and vaccinations].
Débat Zoguéreh D; Ruiz JM
Sante; 2000; 10(3):211-9. PubMed ID: 11022154
[TBL] [Abstract][Full Text] [Related]
17. Immunization for persons infected with human immunodeficiency virus.
Pancharoen C; Ananworanich J; Thisyakorn U
Curr HIV Res; 2004 Oct; 2(4):293-9. PubMed ID: 15544450
[TBL] [Abstract][Full Text] [Related]
18. Secondary efficacy endpoints of the pentavalent rotavirus vaccine against gastroenteritis in sub-Saharan Africa.
Tapia MD; Armah G; Breiman RF; Dallas MJ; Lewis KD; Sow SO; Rivers SB; Levine MM; Laserson KF; Feikin DR; Victor JC; Ciarlet M; Neuzil KM; Steele AD
Vaccine; 2012 Apr; 30 Suppl 1():A79-85. PubMed ID: 22520141
[TBL] [Abstract][Full Text] [Related]
19. [Vaccinations and systemic diseases. Vaccinations and immunosuppression].
Bouchaud O; Mouas H
Ann Med Interne (Paris); 1998 Oct; 149(6):351-60. PubMed ID: 9853045
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults.
King JC; Treanor J; Fast PE; Wolff M; Yan L; Iacuzio D; Readmond B; O'Brien D; Mallon K; Highsmith WE; Lambert JS; Belshe RB
J Infect Dis; 2000 Feb; 181(2):725-8. PubMed ID: 10669363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
